| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
Health Research Center, Department of Family and Preventive Medicine [M. L. S., K. C., S. E., K-N. M.], and Department of Surgical Pathology [W. S. S.], University of Utah, Salt Lake City, Utah 84108 ; Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024 [J. D. P.]; University of Minnesota, School of Public Health, Minneapolis, Minnesota 55454-1015 [K. A.]; and Division of Research, Kaiser Permanente Medical Care Program, Oakland, California 94611 [D. S.]
There are sex differences in the occurrence of microsatellite instability (MSI) in colon tumors. Taken together with the epidemiological evidence that hormone replacement therapy (HRT) and, less consistently, parity, are inversely associated with colon cancer, it has been hypothesized that estrogens are associated with MSI. The purpose of this study was to evaluate sex-specific differences in the prevalence of MSI in colon tumors and to determine whether reproductive history and hormonal exposures are associated with MSI.
Using data from a population-based case-control study of 1836 cases with MSI data and 2410 population-based controls, we evaluated sex, reproductive factors, and hormone exposure in relation to the presence or absence of MSI in tumors. MSI was evaluated by a panel of 10 tetranucleotide repeats, the noncoding mononucleotide repeat BAT-26, and the coding mononucleotide repeat in transforming growth factor ß receptor type II (TGFßRII). Exposure data on reproduction, hormone use, obesity, and physical activity were obtained from an interviewer-administered questionnaire.
Women were less likely then men to have MSI+ tumors at a young age and more likely to have unstable tumors at an older age; we observed a significant interaction (P < 0.01) between age, sex, and MSI. Evaluation of reproductive factors showed that women who had ever been pregnant had half the risk of MSI+ tumors compared with women who had never been pregnant. In complementary fashion, total ovulatory months were associated with an increased risk of MSI+ tumors [odds ratio (OR), 2.1; 95% confidence interval (CI), 1.1–4.0 comparing MSI+ versus MSI- tumors]. Age at first and last pregnancy did not influence the association. The observed associations were strongest among women <60 years of age at the time of diagnosis. Having used oral contraceptives was associated with a lower risk of MSI+ tumors (OR, 0.7; 95% CI, 0.4–1.2); recent users of HRT were at a reduced risk of MSI+ tumors (OR, 0.8; 95% CI, 0.5–1.4); and women who were former HRT users were at an increased risk of MSI+ tumors (OR, 1.8; 95% CI, 1.1–3.0). Obesity and lack of physical activity were associated with an elevated risk of both MSI+ (OR, 1.7; 95% CI, 0.7–3.3) and MSI- (OR, 2.2; 95% CI, 1.7–3.) tumors in men, but only with MSI- (OR, 1.5; 95% CI, 1.1–2.2) tumors in women.
The excess of MSI+ tumors in women is explained by the excess of MSI+ tumors at older ages. Our data suggest that estrogen exposure in women protects against MSI, whereas the lack of estrogen in older women increases risk of instability. HRT in these older women may, again, reduce the risk of unstable tumors. A model for the way in which estrogens (endogenous, exogenous, and obesity-associated) modify the risk of MSI+ tumors is proposed.
This article has been cited by other articles:
|
|
 |
|
  A. P. Kouzmenko, K.-i. Takeyama, Y. Kawasaki, T. Akiyama, and S. Kato Ligand-dependent interaction between estrogen receptor alpha and adenomatous polyposis coli. Genes Cells, July 1, 2008; 13(7): 723 - 730. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mrkonjic, S. Raptis, R. C. Green, N. Monga, D. Daftary, E. Dicks, H.B. Younghusband, P. S. Parfrey, S. S. Gallinger, J. R. McLaughlin, et al. MSH2 118T>C and MSH6 159C>T promoter polymorphisms and the risk of colorectal cancer Carcinogenesis, December 1, 2007; 28(12): 2575 - 2580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Z. J. Chu, G. Gibson, D. David, and Y. Yen The Surgeon's Role in Cancer Prevention. The Model in Colorectal Carcinoma Ann. Surg. Oncol., November 1, 2007; 14(11): 3054 - 3069. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. T. Campbell, M. Cotterchio, E. Dicks, P. Parfrey, S. Gallinger, and J. R. McLaughlin Excess Body Weight and Colorectal Cancer Risk in Canada: Associations in Subgroups of Clinically Defined Familial Risk of Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1735 - 1744. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Newcomb, Y. Zheng, V. M. Chia, L. M. Morimoto, V. P. Doria-Rose, A. Templeton, S. N. Thibodeau, and J. D. Potter Estrogen Plus Progestin Use, Microsatellite Instability, and the Risk of Colorectal Cancer in Women Cancer Res., August 1, 2007; 67(15): 7534 - 7539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. T. Campbell, L. Edwards, J. R. McLaughlin, J. Green, H. B. Younghusband, and M. O. Woods Cytochrome P450 17A1 and Catechol O-Methyltransferase Polymorphisms and Age at Lynch Syndrome Colon Cancer Onset in Newfoundland Clin. Cancer Res., July 1, 2007; 13(13): 3783 - 3788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Wolf, P. D. Terry, J. D. Potter, and R. M. Bostick Do Factors Related to Endogenous and Exogenous Estrogens Modify the Relationship between Obesity and Risk of Colorectal Adenomas in Women? Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 676 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Bises, E. Bajna, T. Manhardt, W. Gerdenitsch, E. Kallay, and H. S. Cross Gender-Specific Modulation of Markers for Premalignancy by Nutritional Soy and Calcium in the Mouse Colon J. Nutr., January 1, 2007; 137(1): 211S - 215S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Suraweera, J. Haines, A. McCart, P. Rogers, A. Latchford, M. Coster, G. Polanco-Echeverry, T. Guenther, J. Wang, O. Sieber, et al. Genetic determinants modulate susceptibility to pregnancy-associated tumourigenesis in a recombinant line of Min mice Hum. Mol. Genet., December 1, 2006; 15(23): 3429 - 3435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cotterchio, B. A. Boucher, M. Manno, S. Gallinger, A. Okey, and P. Harper Dietary Phytoestrogen Intake Is Associated with Reduced Colorectal Cancer Risk J. Nutr., December 1, 2006; 136(12): 3046 - 3053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Miyamoto, T. Shiozawa, H. Kashima, Y.-Z. Feng, A. Suzuki, M. Kurai, T. Nikaido, and I. Konishi Estrogen Up-Regulates Mismatch Repair Activity in Normal and Malignant Endometrial Glandular Cells Endocrinology, October 1, 2006; 147(10): 4863 - 4870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Pischon, P. H. Lahmann, H. Boeing, C. Friedenreich, T. Norat, A. Tjonneland, J. Halkjaer, K. Overvad, F. Clavel-Chapelon, M.-C. Boutron-Ruault, et al. Body Size and Risk of Colon and Rectal Cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst, July 5, 2006; 98(13): 920 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Chia, P. A. Newcomb, J. Bigler, L. M. Morimoto, S. N. Thibodeau, and J. D. Potter Risk of Microsatellite-Unstable Colorectal Cancer Is Associated Jointly with Smoking and Nonsteroidal Anti-inflammatory Drug Use. Cancer Res., July 1, 2006; 66(13): 6877 - 6883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Wada-Hiraike, O. Imamov, H. Hiraike, K. Hultenby, T. Schwend, Y. Omoto, M. Warner, and J.-A. Gustafsson Role of estrogen receptor beta in colonic epithelium PNAS, February 21, 2006; 103(8): 2959 - 2964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Slattery, C. Sweeney, M. Murtaugh, K. N. Ma, R. K. Wolff, J. D. Potter, B. J. Caan, and W. Samowitz Associations between ER{alpha}, ER{beta}, and AR Genotypes and Colon and Rectal Cancer Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2936 - 2942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Murtaugh, C. Sweeney, K.-n. Ma, B. J. Caan, and M. L. Slattery The CYP1A1 Genotype May Alter the Association of Meat Consumption Patterns and Preparation with the Risk of Colorectal Cancer in Men and Women J. Nutr., February 1, 2005; 135(2): 179 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L.C. Hagemans, Y. T. van der Schouw, M. J.J. de Kleijn, W. A. van Staveren, V. J.M. Pop, G. L. Leusink, and D. E. Grobbee Indicators for the total duration of premenopausal endogenous estrogen exposure in relation to BMD Hum. Reprod., September 1, 2004; 19(9): 2163 - 2169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Curtin, J. Bigler, M. L. Slattery, B. Caan, J. D. Potter, and C. M. Ulrich MTHFR C677T and A1298C Polymorphisms: Diet, Estrogen, and Risk of Colon Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 285 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Slattery, S. Edwards, K. Curtin, D. Schaffer, and S. Neuhausen Associations between Smoking, Passive Smoking, GSTM-1, NAT2, and Rectal Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 882 - 889. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Boyle and M. E. Leon Epidemiology of colorectal cancer Br. Med. Bull., December 1, 2002; 64(1): 1 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M van Rijnsoever, F Grieu, H Elsaleh, D Joseph, and B Iacopetta Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands Gut, December 1, 2002; 51(6): 797 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Mitchell, S. M. Farrington, M. G. Dunlop, and H. Campbell Mismatch Repair Genes hMLH1 and hMSH2 and Colorectal Cancer: A HuGE Review Am. J. Epidemiol., November 15, 2002; 156(10): 885 - 902. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M L Slattery The science and art of molecular epidemiology J. Epidemiol. Community Health, October 1, 2002; 56(10): 728 - 729. [Full Text] [PDF]
|
|
|
|
|
|
L. M. Morimoto, P. A. Newcomb, C. M. Ulrich, R. M. Bostick, C. J. Lais, and J. D. Potter Risk Factors for Hyperplastic and Adenomatous Polyps: Evidence for Malignant Potential? Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1012 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Colangelo, S. M. Gapstur, P. H. Gann, A. R. Dyer, and K. Liu Colorectal Cancer Mortality and Factors Related to the Insulin Resistance Syndrome Cancer Epidemiol. Biomarkers Prev., April 1, 2002; 11(4): 385 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B Shannon, S Gnanasampanthan, J Beilby, and B Iacopetta A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability Gut, April 1, 2002; 50(4): 520 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Woodson, E. Lanza, J. A. Tangrea, P. S. Albert, M. Slattery, J. Pinsky, B. Caan, E. Paskett, F. Iber, J. W. Kikendall, et al. Hormone Replacement Therapy and Colorectal Adenoma Recurrence Among Women in the Polyp Prevention Trial J Natl Cancer Inst, December 5, 2001; 93(23): 1799 - 1805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. R. Stuart, J. G. de Boer, R. Haesevoets, J. Holcroft, J. Kangas, K. Sojonky, E. Thorleifson, A. Thornton, D. F. Walsh, H. Yang, et al. Mutations induced by 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) in cecum and proximal and distal colon of lacI transgenic rats Mutagenesis, September 1, 2001; 16(5): 431 - 437. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
